Empowering Innovation Through Customer-Centric Collaboration IFF (NYSE: IFF) today announced the opening of a new co-creation center in Wageningen, the Netherlands, enhancing its capabilities and facilities to drive research and innovation, to better serve its global customers. The new site will be located in the ‘Food Valley’ of the country, an area that is home to many food multi-nationals and a growing number of start-ups. “This space brings us closer to our key customers, driving … [Read more...] about IFF Opens New Co-Creation Center in Wageningen
IFF
IFF Brings Science-Backed Excipients to Asia Pharmaceutical Industry at CPhIJapan 2024
The pharmaceutical excipient powerhouse will highlight its latest advancements, including controlled release, pediatric, and novel delivery formats to meet Japan’s diverse formulation needs TOKYO – March 26, 2024 – IFF, a global leader in food and beverage, home and personal care, and health, will present its broad portfolio and latest excipient technology to CPhI Japan 2024 at booth 5K21, Tokyo Big Sight, Tokyo from April 17-19.IFF’s Pharma Solutions offers high-quality pharmaceutical … [Read more...] about IFF Brings Science-Backed Excipients to Asia Pharmaceutical Industry at CPhIJapan 2024
IFF Advances Plant-Based Meat Alternatives with High-Moisture Extrusion Investment
Plant protein leader to create novel plant-based recipes using Coperion extrusion systems BRABRAND, Denmark – IFF (NYSE: IFF), a global leader in food and beverage, home and personal care, and health and wellness, is stepping up its game in the world of plant-based meat alternatives. The company has invested in high-moisture extrusion (HME) technology from Coperion, a global leader in extrusion technology. IFF has pioneered many options for meat alternative players along the years, and now … [Read more...] about IFF Advances Plant-Based Meat Alternatives with High-Moisture Extrusion Investment